To include your compound in the COVID-19 Resource Center, submit it here.
Aviragen (formerly Biota Pharmaceuticals Inc.) began a double-blind, placebo-controlled, U.K. Phase IIa
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury